首页> 外文期刊>Frontiers in Genetics >sgRNA-shRNA Structure Mediated SNP Site Editing on Porcine IGF2 Gene by CRISPR/StCas9
【24h】

sgRNA-shRNA Structure Mediated SNP Site Editing on Porcine IGF2 Gene by CRISPR/StCas9

机译:CRISPR / StCas9对猪 IGF2 基因进行sgRNA-shRNA介导的SNP位点编辑

获取原文
获取外文期刊封面目录资料

摘要

The SNP within intron 3 of the porcine IGF2 gene (G3072A) plays an important role for muscle growth and fat deposition in pigs. In this study, the StCas9 derived from Streptococcus thermophilus together with the Drosha-mediated sgRNA-shRNA structure were combined to boost the G to A base editing on the IGF2 SNP site, which we called “SNP editing.” The codon-humanized StCas9 as we previously reported was firstly compared with the prevalently used SpCas9 derived from Streptococcus pyogenes using our idiomatic surrogate report assay, and the StCas9 demonstrated a comparable targeting activity. On the other hand, by combining shRNA with sgRNA, simultaneous gene silencing and genome targeting can be achieved. Thus, the novel IGF2.sgRNA-LIG4.shRNA-IGF2.sgRNA structure was constructed to enhance the sgRNA/Cas9-mediated HDR-based IGF2 SNP editing by silencing the LIG4 gene, which is a key molecule of the HDR’s competitive NHEJ pathway. The sgRNA-shRNA/StCas9 all-in-one expression vector and the IGF2.sgRNA/StCas9 as control were separately used to transfect porcine PK15 cells together with an ssODNs donor for the IGF2 SNP editing. The editing events were detected by the RFLP assay, Sanger sequencing as well as Deep-sequencing, and the Deep-sequencing results finally demonstrated a significant higher HDR-based editing efficiency (16.38%) for our sgRNA-shRNA/StCas9 strategy. In short, we achieved effective IGF2 SNP editing by using the combined sgRNA-shRNA/StCas9 strategy, which will facilitate the further production of base-edited animals and perhaps extend for the gene therapy for the base correction of some genetic diseases.
机译:猪IGF2基因(G3072A)内含子3内的SNP对猪的肌肉生长和脂肪沉积起重要作用。在这项研究中,将源自嗜热链球菌的StCas9与Drosha介导的sgRNA-shRNA结构结合在一起,以在IGF2 SNP位点上将G增强为A碱基编辑,我们称之为“ SNP编辑”。首先,使用我们惯用的替代报告分析方法,将我们先前报道的密码子人源化StCas9与流行的化脓性链球菌衍生的SpCas9进行了比较,并且StCas9表现出可比的靶向活性。另一方面,通过将shRNA与sgRNA结合,可以同时实现基因沉默和基因组靶向。因此,构建了新的IGF2.sgRNA-LIG4.shRNA-IGF2.sgRNA结构,通过沉默LIG4基因来增强sgRNA / Cas9介导的基于HDR的IGF2 SNP编辑,这是HDR竞争性NHEJ途径的关键分子。分别使用sgRNA-shRNA / StCas9多合一表达载体和IGF2.sgRNA / StCas9作为对照,与ssODNs供体一起转染猪PK15细胞,以进行IGF2 SNP编辑。通过RFLP分析,Sanger测序以及深度测序检测到了编辑事件,深度测序结果最终证明了我们的sgRNA-shRNA / StCas9策略基于HDR的编辑效率显着提高(16.38%)。简而言之,通过使用sgRNA-shRNA / StCas9组合策略,我们实现了有效的IGF2 SNP编辑,这将有助于基础编辑动物的进一步生产,并可能扩展到基因治疗的基础,以纠正某些遗传性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号